Department of Medical Microbiology and Infection Control, Amsterdam UMC, location AMC, Amsterdam, The Netherlands.
Department of Medical Microbiology, Jeroen Bosch Hospital, 's Hertogenbosch, The Netherlands.
J Clin Lab Anal. 2024 Mar;38(5):e25004. doi: 10.1002/jcla.25004. Epub 2024 Mar 7.
Urinary tract infections are responsible for a significant worldwide disease burden. Performing urine culture is time consuming and labor intensive. Urine flow cytometry might provide a quick and reliable method to screen for urinary tract infection.
We analyzed routinely collected urine samples received between 2020 and 2022 from both inpatients and outpatients. The UF-4000 urine flow cytometer was implemented with an optimal threshold for positivity of ≥100 bacteria/μL. We thereafter validated the prognostic value to detect the presence of urinary tract infection (UTI) based on bacterial (BACT), leukocyte (WBC), and yeast-like cell (YLC) counts combined with the bacterial morphology (UF gram-flag).
In the first phase, in 2019, the UF-4000 was implemented using 970 urine samples. In the second phase, between 2020 and 2022, the validation was performed in 42,958 midstream urine samples. The UF-4000 screen resulted in a 37% (n = 15,895) decrease in performed urine cultures. Uropathogens were identified in 18,673 (69%) positively flagged urine samples. BACT > 10.000/μL combined with a gram-negative flag had a >90% positive predictive value for the presence of gram-negative uropathogens. The absence of gram-positive flag or YLC had high negative predictive values (99% and >99%, respectively) and are, therefore, best used to rule out the presence of gram-positive bacteria or yeast. WBC counts did not add to the prediction of uropathogens.
Implementation of the UF-4000 in routine practice decreased the number of cultured urine samples by 37%. Bacterial cell counts were highly predictive for the presence of UTI, especially when combined with the presence of a gram-negative flag.
尿路感染在全球范围内造成了巨大的疾病负担。进行尿液培养既耗时又费力。尿液流式细胞术可能提供一种快速可靠的方法来筛查尿路感染。
我们分析了 2020 年至 2022 年间住院患者和门诊患者常规收集的尿液样本。UF-4000 尿液流式细胞仪采用阳性界值≥100 个细菌/μL 来实施。此后,我们验证了基于细菌(BACT)、白细胞(WBC)和酵母样细胞(YLC)计数以及细菌形态(UF 革兰氏染色)相结合来检测尿路感染(UTI)存在的预后价值。
在第一阶段,于 2019 年,UF-4000 使用了 970 个尿液样本。在第二阶段,2020 年至 2022 年期间,在 42958 份中段尿液样本中进行了验证。UF-4000 筛查导致进行的尿液培养减少了 37%(n=15895)。在 18673 份(69%)被阳性标记的尿液样本中鉴定出了尿路病原体。BACT>10000/μL 联合革兰氏阴性标记对革兰氏阴性尿路病原体的阳性预测值>90%。缺乏革兰氏阳性标记或 YLC 具有较高的阴性预测值(分别为 99%和>99%),因此,最好用于排除革兰氏阳性细菌或酵母的存在。WBC 计数对预测尿路病原体没有帮助。
UF-4000 在常规实践中的实施使培养的尿液样本数量减少了 37%。细菌细胞计数对 UTI 的存在具有高度预测性,尤其是当与革兰氏阴性标记同时存在时。